GENPHARM SERVICES

"Your Partner of Choice and your gate to the Middle East and North Africa (MENA) Pharmaceutical World"

ABOUT US

Genpharm Services is a financially sound privately owned company based in the Dubai Science Park (DSP), U.A.E. We provide fast-track Market Access to specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA) region. We focus on innovative and orphan drugs in areas of unmet medical needs, rare genetic disorders and autoimmune diseases.

Pharmaceutical Strategic Advice

"We also provide Management Consultancy for companies aiming at expanding directly into this dynamic region of high growth. We advise on strategies, structures and operating business models in line with the respective company priorities and portfolio. "

Aspire Educational Series: Central Core Disease (CCD) - Part 20

Central core disease (CCD) is a form of muscular dystrophy. It falls under the category of congenital myopathies (which means it’s an inherited condition), in which type 1 skeletal muscle fibers exhibit amorphous area -scores’ that lack mitochondria and oxidative enzyme activity that run the length of the myofibre. Central core disease affects males and females in equal numbers. The exact incidence and prevalence of CCD are unknown. CCD is believed to be the most common form of congenital myopathy, which as a group occurs in 6 out of every 100,000 live births.

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan honoring Genpharm for their role in raising awareness on Rare Diseases and for their contribution on Rare Disease Day

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Culture and the development of knowledge, president of the UAE Genetic Diseases Association, honored several specialized experts in rare diseases, as part of the annual Emirates International Award for reducing genetic diseases "rare disease category" in its third session.

Films from around the world addressing the challenges of life with a rare disease.

The Rare Disease Film Festival is a new event showcasing films from around the world which address the challenges of life with a rare disease. It will be held Oct. 3rd, 2017 in Boston, MA. We believe increased awareness can connect patient families, inspire conversations about translation applications of current science, lead to new paths for research and save lives. These films put the often abstract and dire clinical information into the context of real people living their lives.

GENPHARM Services - Your Gateway to the MENA Pharmaceutical Market

We are a specialty pharmaceutical marketing and consulting company, providing our strategic partners with fast and sustainable market access into the MENA (Middle East & North Africa) region, including business development, in-licensing and more. We operate through evidence-based medicine and the highest ethical standards. Our expertise is based on an in-depth knowledge of the pharmaceutical market and the local business culture. Furthermore, our vast experience and the trusted network of partners allow us to deliver market opportunities for specialty, rare disease, biotech, and innovative healthcare organizations.

The MENA region has been experiencing fast economic and sustainable GDP growth. This positive outlook is driven by several factors providing pharmaceutical companies with untapped regional opportunities...
The healthcare sector in the MENA region has been experiencing sustainable double digit growth. Driven by unmet medical needs and increased medical public awareness, governments have been heavily investing in both infrastructure and access
We operate through a holistic market approach. We manage all relevant stakeholders for our partners, including Physicians, Patient groups, distributors and payers. Our expertise include KOL management, advocacy and CME programs..
Genpharm Services is managed by highly experienced Pharma executives. The operations are led by staff with a strong track record in senior leadership roles in multinational pharmaceutical organizations...